OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
42 hedge funds and large institutions have $13.1M invested in OncoMed Pharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
42
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.42M | |
| 2 | +$300K | |
| 3 | +$56.5K | |
| 4 |
BC
Birchview Capital
Burlington,
Vermont
|
+$40.3K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$40K |
Top Sellers
| 1 | -$1.35M | |
| 2 | -$839K | |
| 3 | -$674K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$491K |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$465K |